Manuel Muro *

Autor invitado por SIIC

El trabajo aporta datos importantes en la diversidad del gen MICA en genética de poblaciones

DIVERSIDAD ALELICA Y HAPLOTIPICA DEL GEN MICA EN UNA POBLACION ESPAÑOLA

Nuestros datos indican que la diversidad alélica en la población del sureste de España es similar a otras poblaciones caucasoides, aunque encontramos una serie de alelos menos frecuentes, además de asociaciones haplotípicas no descritas en otras poblaciones de este origen.

*Manuel Muro
describe para SIIC los aspectos relevantes de su trabajo
ALLELIC DIVERSITY OF MICA GENE AND MICA/HLA-B HAPLOTYPIC VARIATION IN A POPULATION OF THE MURCIA REFION IN SOUTHEASTERN SPAIN
Institución principal de la investigación
*Hospital Universitario Virgen de la Arrixaca, Murcia, España
Imprimir nota

Comprar este artículo
Otros artículos escogidos

Referencias bibliográficas
1. Bahram S, Bresnahan M, Geraghty DE, Spies T. A second lineage of mammalian major histocompatibility complex class I genes. Proc Natl Acad Sci USA 91:6259-6263, 1994.
2. Grubic Z, Stingl K, Zunec R, Car H, Cecuk-Jelicic E, Brkljacic-Kerhin V. Linkage disequilibria between human leucocyte antigen-B and closely linked microsatellites in the Croatian population. Tissue Antigens 69:86-94, 2006.
3. Zwirner NW, Fernandez-Viña MA, Stastny P. MICA, a new polymorphic HLA-related antigen, is expressed mainly by keratinocytes, endothelial cells, and monocytes. Immunogenetics 47:139-148, 1998.
4. Gannage M, Buzyn A, Bogiatzi SI, Lambert M, Soumelis V, Dal Cortivo L. Induction of NKG2D ligands by gamma radiation and tumor necrosis factor-alpha may participate in the tissue damage during acute graft-versus-host-disease. Transplantation 27:911-915, 2008.
5. Suemizu H, Radosavljevic M, Kimura M, et al. A basolateral sorting motif in the MICA cytoplasmic tail. Proc Natl Acad Sci USA 99:2971-2976, 2002.
6. Eagle RA, Taherne JA, Ashiru O, Wills MR, Trowsdale J. Regulation of NKG2D ligand gene expression. Hum Immunol 67:159-169, 2006.
7. Steinle A, Li P, Morris DL, et al. Interactions of human NKG2D with its ligand MICA, MICB and homologs of the mouse RAE-1 protein family. Immunogenetics 53:279-87, 2001.
8. Reinders J, Rozemuller EH, Van der Ven KJW, Caillat-Zucman S, Slootweg PJ, Weger RA, Tilanus MGJ. MHC class I chain-related gene A diversity in head and neck squamous cell carcinoma. Hum Immunol 67:196-203, 2005.
9. Jordanova ES, Gorter A, Ayachi O, Prins F, Durrant LG, Kenter GG. Human leucocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14:2028-2035, 2008.
10. Molinero LL, Damaica CI, Fuertes MB, Girart MV, Rossi LE, Zwirner NW. Intracellular expression of MICA in activated CD4 T lymphocytes and protection from NK cell-mediated MICA-dependent cytotoxicity. Hum Immunol 67:170-182, 2006.
11. Arreygue-Garcia N, Daneri-Navarro A, del Toro-Arreola A, Cid-Arregui A, Gonzalez-Ramella O, Jave-Suarez LF, et al. Augmented serum level of major histocompatibility complex class I-related chain A (MICA) protein and reduced NKG2D expression on NK and T cells in patients with cervical cancer and precursor lesions. BMC Cancer 8:16, 2008.
12. Fuertes MB, Girart MV, Molinero LL, Domaica CI, Rossi LE, Barrio MM, et al. Intracellular retention of the NKG2D ligand MHC class I chain-related gene A in human melanomas confers immune privilege and prevents NK-cell-mediated cytotoxicity. J Immunol 180:4606-4614, 2008.
13. Jinushi M, Vanneman M, Munshi NC, Tai YT, Prabhala RH, Rizt J, et al. MHC class I chain-related protein A antibodies and shedding are associated with the progression of multiple myeloma. Proc Natl Acad Sci USA 105:1285-1290, 2008.
14. Mizutani K, Terasaki PI, Shih RMJ, Pei R, Ozawa M, Lee J. Frequency of MIC antibody in rejected renal transplant patients without HLA antibody. Hum Immunol 67:223-229, 2006.
15. Suarez-Alvarez B, López-Vazquez A, González MZ, Fdez-Morera JL, Diaz-Molina B, Blanco-Gelaz MA, Pascual D, Martinez-Borra J, Muro M, Álvarez-López MR, López-Larrea C. The relationship of Anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant 7:1842-1848, 2007.
16. Stastny P. Introduction: MICA/MICB in innate immunity, adaptative immunity, autoimmunity, cancer, and in the immune response to transplants. Hum Immunol 67:141-144, 2006.
17. Caillat-Zucman S. How NKG2D ligands trigger autoimmunity? Hum Immunol 67:204-207, 2005.
18. Muro M, Marín L, Torío A, Moya-Quiles MR, Minguela A, Rosique-Roman J, Sanchís MJ, Garcia-Calatayud MC, García-Alonso AM, Álvarez-López MR. HLA polymorphism in the Murcia Population (Spain) in the Cradle of the Archaeologic Iberians. Hum Immunol 62:910-921, 2001.
19. Muro M, Moya-Quiles MR, Botella C, Álvarez-López MR. Prevalence of C282Y, H63D and S65C mutations of the hemochromatosis (HFE) gene in a population from South-Eastern Spain (Murcia Region). Clinical Genetics 71:97-98, 2007.
20. Muro M, Moya-Quiles MR, Botella C, Garcia L, Minguela A, Álvarez-López MR. Genetic relationship between Murcia Region (SE Spain) and other Iberian and Mediterranean populations with respect to HFE mutation distribution. Ann Hematol 86:455-457, 2007.
21. Muro M, Marin L, Torio A, Pagan JA, Álvarez-López MR. CCL5/RANTES chemokine polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int J Immunogenetics 35:19-23, 2008.
22. Gao X, Single RM, Karacki P, Marti D, O´Brien SJ, Carrington M. Diversity of MICA and linkage disequilibrim with HLA-B in two North American populations. Hum Immunol 67:152-158, 2006.
23. Marin ML, Savioli CR, Yamamoto JH, Kalil J, Goldberg AC. MICA polymorphism in a sample of the Sao Paulo population, Brazil. In: Immunobiology of the Human MHC. Vol II. Hansen JA (eds.). PJ Schmidt Grafisk, Vojens, Denmark, pp. 476-479, 2006.
24. Muñoz-Saa I, Cambra A, Pallares L, Espinosa G, Juan A, Pujalte F, Matamoros N, Mila J, Julia MR. Allelic diversity and affinity variants of MICA are imbalanced in Spanish patients with Behcet´s disease. Scand J Immunol 64:77-82, 2006.
25. Albert E, Yao Z, Chandanayingyong D, Witter K, Volgger A, Picantelli D, et al. Anthropology/human genetic diversity population reports. MICA report. In: Hansen JA, Dupont B (eds): HLA 2004: Immunobiology of the Human MHC. Proceedings of the 13th International Histocompatibility Workshop and Congress. Seatle, WA, IHWG Press, 2004.
26. Petersdorf EW, Shuler KB, Longron GM, Spies T, Hansen JA. Population study of allelic diversity in the human MHC class I-related MIC-A gene. Immunogenetics 49;605-612, 1999.
27. Gonzalez S, Brautbar C, Martinez-Borra J, et al. Polymorphism in MICA rather than HLA-B/C genes is associated with psoriatic arthritis in the Jewish population. Hum Immunol 62:632-638, 2001.
28. Zhang Y, Han M, Vorhaben R, Giang C, Lavingia B, Stastny P. Study of MICA alleles in 201 African Americans by multiplexed single nucleotide extension (MSNE) typing. Hum Immunol 64:130, 2003.
29. Collins RWM. Human MHC class I chain related (MIC) genes: their biological function and relevance to disease and transplantation. Eur J Immunogenet 31:105-114, 2004.
30. Hughes EH, Collins RWM, Kondeatis E, Wallace GR, Graham EM, Vaughan RW, Stanford MR. Associations of major histocompatibility complex class I chain-related molecule polymorphisms with Behcet´s disease in Caucasian patients. Tissue Antigens 66:195-199, 2005.
31. Zou Y, Han M, Wang Z, Stasny P. MICA allele-level typing by sequence-based typing with computerized assignment of polymorphic sites and short tandem repeats within the transmembrane region. Hum Immunol 67:145-151, 2006.
32. Piancatelli D, Del Beato T, Oumhani K, El Aouad R, Adorno D. MICA polymorphism in a population from North Morocco, Metalsa Berbers, using sequence-based typing. Hum Immunol 66:931-936, 2005.
33. Romphruk AV, Romphruk A Choonhakam C, Puapairoj C, Inoko H, Leelayuwat C. Major histocompatibility complex class I chain-related gene A in Thai psoriasis patients: MICA association as a part of human leukocyte antigen-B-Cw haplotypes. Tissue Antigens 63:547-554, 2004.
34. Arnaiz-Villena A, Benmamar D, Alvarez M, et al. HLA allele and haplotype frequencies in Algerians. Relatedness to Spaniards and Basques. Hum Immunol 43:259-268, 1995.
35. Tian W, Boggs DA, Uko G, Essiet A, Inyama M, Banjoko B, et al. MICA, HLA-B haplotypic variation in five population groups of sub-Saharan African ancestry. Genes Immunity 4:500-505, 2003.
36. Gong W, Yang J, Yao F, X Lingdi, Fan L. Analysis on polymorphism in exons 2, 3 and 4 of the MICA gene in three different Chinese populations. In: Immunobiology of the Human MHC. Vol II. Hansen JA (eds.). PJ Schmidt Grafisk, Vojens, Denmark, pp .470-472, 2006.
37. Bolognesi E, D´Alfonso S, Rolando V, Fasano ME, Practico L, Momigliano-Richiardi P. MICA and MICB microsatellite alleles in HLA extended haplotypes. Eur J Immunogenet 28:523, 2001.
38. Zhang Y, Lazaro AM, Zou Y, Lavingia B, Moraes EM, Moraes RJ, Stastny P. MICA polymorphism in South American Indians. Immunogenetics 53:900, 2002.
39. Komatsu-Wakui M, Tokunaga K, Ishikawa Y, et al. Wide distribution of the MICA-MICB null haplotype in East Asians. Tissue Antigens 57:1, 2001.
40. Pyo CW, Hur SS, Kim YK, Choi HB, Kin TY, Kim TG. Distribution of MICA alleles and haplotypes associated with HLA in the Korean population. Hum Immunol 64:378, 2003.
41. Zhang Y, Stastny P. MICA antigens stimulate T cell proliferation and cell-mediated cytotoxicity. Hum Immunol 67:215-222, 2006.
42. Kitcharoen K, Witt CS, Romphruk AV, Christiansen FT, Leelayuwat C. MICA, MICb, and MHC beta block matching in bone marrow transplantation. Hum Immunol 67:238-246, 2006.
43. Marin L, Muro M, Moya-Quiles MR, Miras M, Minguela A, Bermejo J, Sánchez-Bueno F, Parrilla P, Álvarez-López MR. Study of Fas (CD95) and FasL (CD178) polymorphism in liver transplant recipients. Tissue Antigens 67:117-126, 2006.

Otros artículos de Manuel Muro

Minguela A, Miras M, Bermejo J, Sánchez-Bueno F, López-Alvarez R, Moya-Quiles MR, Muro M, Ontañón J, Garcia-Alonso AM, Parrilla P, Alvarez-López MR. HBV and HCV Infections and Acute Rejection Differentially modulate CD95 and CD28 expression on peripheral blood lymphocytes after liver transplantation. Human Immunol 67(11):884-893, 2006.
Gómez-Mateo J, Marin L, López-Alvarez MR, Moya-Quiles MR, Miras M, Marin-Moreno I, Botella C, Parrilla P, Álvarez-López MR, Muro M. TGF-beta1 gene polymorphism in liver graft recipients. Transplant Immunol 17(1):55-57, 2006.
Muro M, Moya-Quiles MR, Botella C, Álvarez-López MR. Prevalence of C282Y, H63D and S65C mutations of the hemochromatosis (HFE) gene in a population from South-Eastern Spain (Murcia Region). Clinical Genetics 71(1):97-98, 2007.
Moya-Quiles R, Alvarez R, Miras M, Gómez-Mateo J, López-Alvarez R, Marin-Moreno I, Martinez-Barba E, Sánchez-Mozo P, Gomez M, Arnal F, Sánchez-Bueno F, Marin L, García-Alonso A, Minguela A, Muro M, Parrilla P, Alonso C, Álvarez-López R. Spanish Group of Transplant Immunology and Immunotolerance. Impact of recipient HLA-C in liver transplant: A protective effect of HLA-Cw*07 on acute rejection. Human Immunol 68(1):51-58, 2007.
Muro M, Moya-Quiles MR, Botella C, Garcia L, Minguela A, Álvarez-López MR. Genetic relationship between Murcia Region (SE Spain) and other Iberian and Mediterranean populations with respect to HFE mutation distribution. Ann Hematol 86(6):455-457, 2007.
Muro M, Llorente S, Gonzalez-Soriano MJ, Minguela A, Gimeno L, Álvarez-López MR. Pre-formed Donor-Specific Alloantibodies (DSA) detected only by Luminex technology using HLA-coated microspheres and causing acute humoral rejection and kidney graft dysfunction. En: Clinical Transplans, Terasaki PI (ed). Los Angeles, pp. 379-383, 2007.
Suarez-Alvarez B, López-Vazquez A, González MZ, Fdez-Morera JL, Diaz-Molina B, Blanco-Gelaz MA, Pascual D, Martinez-Borra J, Muro M, Álvarez-López MR, López-Larrea C. The relatioship of Anti-MICA antibodies and MICA expression with heart allograft rejection. Am J Transplant 7(7):1842-1848, 2007.
Muro M, Palacios S, Moya-Quiles MR, Candela M, Álvarez-López MR. Acute haemolytic transfusion reaction secondary to HLA alloimmunization. Int Jnl Lab Haematol 30:84-86, 2008.
Muro M, Marin L, Torio A, Pagan JA, Álvarez-López MR. CCL5/RANTES chemokine polymorphisms are not associated with atopic and nonatopic asthma in a Spanish population. Int J Immunogenetics 35:19-23, 2008.
Muro M, Rojas G, Botella C, Miras M, Campillo JA, Minguela A, Sánchez-Bueno F, Bermejo J, Ramirez P, Álvarez-López MR. CT60A/G marker of the 3´-UTR of CTLA-4 gene and liver transplant. Transplant Immunol 18(3):246-249, 2008.
Muro M, Rivera J, Botella C, Campillo JA, Ferrer F, Álvarez-López MR. HLA-DR antibodies in Transfusion-Related Acute Lung Injury (TRALI): A case report. Transfusion Apheresis Science 38:209-212, 2008.

Para comunicarse con Manuel Muro mencionar a SIIC como referencia:
manuel.muro@carm.es

---

Acerca del trabajo completo

DIVERSIDAD ALELICA Y HAPLOTIPICA DEL GEN MICA EN UNA POBLACION ESPAÑOLA

Título original en castellano
DIVERSIDAD ALELICA DEL GEN MICA Y VARIACION HAPLOTIPICA MICA/HLA-B EN UNA POBLACION DE LA REGION DE MURCIA EN EL SURESTE DE ESPAÑA

Autor
Manuel Muro¹
1 Doctor, Hospital Universitario Virgen de la Arrixaca, Murcia, España, Facultativo Especialistade Area

Acceso a la fuente original
Human Immunology
http://www.elsevier.com/locate/humimm

El artículo se relaciona estrictamente con las especialidades de siicsalud
El artículo se conecta secundariamente con las especialidades